1 Study Coverage
1.1 Amyotrophic Lateral Sclerosis (ALS) Product Introduction
1.2 Market by Type
1.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 Other
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales Estimates and Forecasts 2017-2028
2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Estimates and Forecasts 2017-2028
2.3 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region
2.4.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022)
2.4.2 Global Sales Amyotrophic Lateral Sclerosis (ALS) by Region (2023-2028)
2.5 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region
2.5.1 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022)
2.5.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturers
3.1.1 Global Top Amyotrophic Lateral Sclerosis (ALS) Manufacturers by Sales (2017-2022)
3.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Amyotrophic Lateral Sclerosis (ALS) in 2021
3.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturers
3.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturers (2017-2022)
3.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (ALS) Revenue in 2021
3.3 Global Amyotrophic Lateral Sclerosis (ALS) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Amyotrophic Lateral Sclerosis (ALS) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type
4.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Historical Sales by Type (2017-2022)
4.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Forecasted Sales by Type (2023-2028)
4.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
4.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type
4.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Historical Revenue by Type (2017-2022)
4.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)
4.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Type
4.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2022)
4.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application
5.1.1 Global Amyotrophic Lateral Sclerosis (ALS) Historical Sales by Application (2017-2022)
5.1.2 Global Amyotrophic Lateral Sclerosis (ALS) Forecasted Sales by Application (2023-2028)
5.1.3 Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
5.2 Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application
5.2.1 Global Amyotrophic Lateral Sclerosis (ALS) Historical Revenue by Application (2017-2022)
5.2.2 Global Amyotrophic Lateral Sclerosis (ALS) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)
5.3 Global Amyotrophic Lateral Sclerosis (ALS) Price by Application
5.3.1 Global Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2022)
5.3.2 Global Amyotrophic Lateral Sclerosis (ALS) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis (ALS) Market Size by Type
6.1.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
6.1.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2028)
6.2 North America Amyotrophic Lateral Sclerosis (ALS) Market Size by Application
6.2.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
6.2.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2028)
6.3 North America Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
6.3.1 North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2028)
6.3.2 North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size by Type
7.1.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
7.1.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2028)
7.2 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size by Application
7.2.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
7.2.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2028)
7.3 Europe Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
7.3.1 Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2028)
7.3.2 Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size by Type
8.1.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
8.1.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2028)
8.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size by Application
8.2.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
8.2.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2028)
8.3 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Market Size by Region
8.3.1 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2028)
8.3.2 Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Market Size by Type
9.1.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
9.1.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2028)
9.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Market Size by Application
9.2.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
9.2.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2028)
9.3 Latin America Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
9.3.1 Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2028)
9.3.2 Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Size by Type
10.1.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2028)
10.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Size by Application
10.2.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2028)
10.3 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Market Size by Country
10.3.1 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Mitsubishi Tanabe Pharma
11.1.1 Mitsubishi Tanabe Pharma Corporation Information
11.1.2 Mitsubishi Tanabe Pharma Overview
11.1.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Mitsubishi Tanabe Pharma Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Mylan Pharma
11.3.1 Mylan Pharma Corporation Information
11.3.2 Mylan Pharma Overview
11.3.3 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mylan Pharma Recent Developments
11.4 Apotex
11.4.1 Apotex Corporation Information
11.4.2 Apotex Overview
11.4.3 Apotex Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Apotex Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Apotex Recent Developments
11.5 Glemark Generics
11.5.1 Glemark Generics Corporation Information
11.5.2 Glemark Generics Overview
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Glemark Generics Recent Developments
11.6 Covis Pharma
11.6.1 Covis Pharma Corporation Information
11.6.2 Covis Pharma Overview
11.6.3 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Covis Pharma Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Corporation Information
11.7.2 Sun Pharma Overview
11.7.3 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sun Pharma Recent Developments
11.8 Lunan Pharma
11.8.1 Lunan Pharma Corporation Information
11.8.2 Lunan Pharma Overview
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Lunan Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Amyotrophic Lateral Sclerosis (ALS) Industry Chain Analysis
12.2 Amyotrophic Lateral Sclerosis (ALS) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Amyotrophic Lateral Sclerosis (ALS) Production Mode & Process
12.4 Amyotrophic Lateral Sclerosis (ALS) Sales and Marketing
12.4.1 Amyotrophic Lateral Sclerosis (ALS) Sales Channels
12.4.2 Amyotrophic Lateral Sclerosis (ALS) Distributors
12.5 Amyotrophic Lateral Sclerosis (ALS) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Amyotrophic Lateral Sclerosis (ALS) Industry Trends
13.2 Amyotrophic Lateral Sclerosis (ALS) Market Drivers
13.3 Amyotrophic Lateral Sclerosis (ALS) Market Challenges
13.4 Amyotrophic Lateral Sclerosis (ALS) Market Restraints
14 Key Findings in The Global Amyotrophic Lateral Sclerosis (ALS) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Riluzole
Table 3. Major Manufacturers of Edaravone (Radicava)
Table 4. Major Manufacturers of Other
Table 5. Global Amyotrophic Lateral Sclerosis (ALS) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)
Table 8. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2022)
Table 9. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2023-2028) & (K MT)
Table 10. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2023-2028)
Table 11. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2017-2022)
Table 13. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region (2023-2028)
Table 15. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Manufacturers (2017-2022) & (K MT)
Table 16. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Manufacturers (2017-2022)
Table 17. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Manufacturers (2017-2022)
Table 19. Amyotrophic Lateral Sclerosis (ALS) Price by Manufacturers (2017-2022) &(USD/MT)
Table 20. Global Amyotrophic Lateral Sclerosis (ALS) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Amyotrophic Lateral Sclerosis (ALS) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis (ALS) as of 2021)
Table 22. Amyotrophic Lateral Sclerosis (ALS) Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Amyotrophic Lateral Sclerosis (ALS) Product Offered
Table 24. Date of Manufacturers Enter into Amyotrophic Lateral Sclerosis (ALS) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 27. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 28. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Type (2017-2022)
Table 29. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Type (2023-2028)
Table 30. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Type (2017-2022)
Table 33. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Type (2023-2028)
Table 34. Amyotrophic Lateral Sclerosis (ALS) Price by Type (2017-2022) & (USD/MT)
Table 35. Global Amyotrophic Lateral Sclerosis (ALS) Price Forecast by Type (2023-2028) & (USD/MT)
Table 36. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 37. Global Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 38. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Application (2017-2022)
Table 39. Global Amyotrophic Lateral Sclerosis (ALS) Sales Share by Application (2023-2028)
Table 40. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Application (2017-2022)
Table 43. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Application (2023-2028)
Table 44. Amyotrophic Lateral Sclerosis (ALS) Price by Application (2017-2022) & (USD/MT)
Table 45. Global Amyotrophic Lateral Sclerosis (ALS) Price Forecast by Application (2023-2028) & (USD/MT)
Table 46. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 47. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 48. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 51. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 52. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)
Table 55. North America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)
Table 56. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 59. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 60. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 63. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 64. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)
Table 67. Europe Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)
Table 68. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 71. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 72. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 75. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 76. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2017-2022) & (K MT)
Table 79. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales by Region (2023-2028) & (K MT)
Table 80. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 83. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 84. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 87. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 88. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)
Table 91. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)
Table 92. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2017-2022) & (K MT)
Table 95. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Type (2023-2028) & (K MT)
Table 96. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2017-2022) & (K MT)
Table 99. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Application (2023-2028) & (K MT)
Table 100. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2017-2022) & (K MT)
Table 103. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales by Country (2023-2028) & (K MT)
Table 104. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue by Country (2023-2028) & (US$ Million)
Table 106. Mitsubishi Tanabe Pharma Corporation Information
Table 107. Mitsubishi Tanabe Pharma Description and Major Businesses
Table 108. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 109. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Mitsubishi Tanabe Pharma Recent Developments
Table 111. Sanofi Corporation Information
Table 112. Sanofi Description and Major Businesses
Table 113. Sanofi Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 114. Sanofi Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Sanofi Recent Developments
Table 116. Mylan Pharma Corporation Information
Table 117. Mylan Pharma Description and Major Businesses
Table 118. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 119. Mylan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Mylan Pharma Recent Developments
Table 121. Apotex Corporation Information
Table 122. Apotex Description and Major Businesses
Table 123. Apotex Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 124. Apotex Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Apotex Recent Developments
Table 126. Glemark Generics Corporation Information
Table 127. Glemark Generics Description and Major Businesses
Table 128. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 129. Glemark Generics Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Glemark Generics Recent Developments
Table 131. Covis Pharma Corporation Information
Table 132. Covis Pharma Description and Major Businesses
Table 133. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 134. Covis Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Covis Pharma Recent Developments
Table 136. Sun Pharma Corporation Information
Table 137. Sun Pharma Description and Major Businesses
Table 138. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 139. Sun Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Sun Pharma Recent Developments
Table 141. Lunan Pharma Corporation Information
Table 142. Lunan Pharma Description and Major Businesses
Table 143. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 144. Lunan Pharma Amyotrophic Lateral Sclerosis (ALS) Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Lunan Pharma Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Amyotrophic Lateral Sclerosis (ALS) Distributors List
Table 149. Amyotrophic Lateral Sclerosis (ALS) Customers List
Table 150. Amyotrophic Lateral Sclerosis (ALS) Market Trends
Table 151. Amyotrophic Lateral Sclerosis (ALS) Market Drivers
Table 152. Amyotrophic Lateral Sclerosis (ALS) Market Challenges
Table 153. Amyotrophic Lateral Sclerosis (ALS) Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis (ALS) Product Picture
Figure 3. Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Type in 2021 & 2028
Figure 3. Riluzole Product Picture
Figure 4. Edaravone (Radicava) Product Picture
Figure 5. Other Product Picture
Figure 6. Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Application in 2021 & 2028
Figure 7. Hospital
Figure 8. Drugs Store
Figure 9. Other
Figure 10. Amyotrophic Lateral Sclerosis (ALS) Report Years Considered
Figure 11. Global Amyotrophic Lateral Sclerosis (ALS) Sales 2017-2028 (K MT)
Figure 12. Global Amyotrophic Lateral Sclerosis (ALS) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Amyotrophic Lateral Sclerosis (ALS) Revenue 2017-2028 (US$ Million)
Figure 14. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2017-2022)
Figure 16. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Region (2023-2028)
Figure 17. North America Amyotrophic Lateral Sclerosis (ALS) Sales YoY (2017-2028) & (K MT)
Figure 18. North America Amyotrophic Lateral Sclerosis (ALS) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Amyotrophic Lateral Sclerosis (ALS) Sales YoY (2017-2028) & (K MT)
Figure 20. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Sales YoY (2017-2028) & (K MT)
Figure 22. Asia-Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales YoY (2017-2028) & (K MT)
Figure 24. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Sales YoY (2017-2028) & (K MT)
Figure 26. Middle East & Africa Amyotrophic Lateral Sclerosis (ALS) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Amyotrophic Lateral Sclerosis (ALS) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Amyotrophic Lateral Sclerosis (ALS) in the World: Market Share by Amyotrophic Lateral Sclerosis (ALS) Revenue in 2021
Figure 29. Global Amyotrophic Lateral Sclerosis (ALS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 31. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)
Figure 32. Global Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 33. Global Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)
Figure 34. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 35. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)
Figure 36. North America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 37. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)
Figure 38. North America Amyotrophic Lateral Sclerosis (ALS) Sales Share by Country (2017-2028)
Figure 39. North America Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Country (2017-2028)
Figure 40. U.S. Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 43. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)
Figure 44. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 45. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)
Figure 46. Europe Amyotrophic Lateral Sclerosis (ALS) Sales Share by Country (2017-2028)
Figure 47. Europe Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Country (2017-2028)
Figure 48. Germany Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 49. France Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Region (2017-2028)
Figure 59. China Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 62. India Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 70. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 72. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Amyotrophic Lateral Sclerosis (ALS) Sales Share by Country (2017-2028)
Figure 74. Latin America Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Country (2017-2028)
Figure 75. Mexico Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Amyotrophic Lateral Sclerosis (ALS) Revenue Share by Country (2017-2028)
Figure 84. Turkey Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 86. U.A.E Amyotrophic Lateral Sclerosis (ALS) Revenue (2017-2028) & (US$ Million)
Figure 87. Amyotrophic Lateral Sclerosis (ALS) Value Chain
Figure 88. Amyotrophic Lateral Sclerosis (ALS) Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
